Uniting the world through cannabis

Experion is a Canadian licensed producer of premium cannabis focused on growing craft high quality strains within a state of the art facility skilled at maneuvering the regulatory environment, getting products into the market for distribution and building brand recognition. Is there opportunity? Plenty.


There has never been a better time:

  • Cannabis consumers are projected to spend U.S. $5.2 billion in Canada by 2024

  • The medical marijuana market in Canada has the potential to be U.S. $1.88 billion by 2025

  • Global cannabis spending is expected to reach U.S. $66.3 billion by the end of 2025

  1. Contact Investor Relations

Current markets

(TSXV:EXP) (OTCQB:EXPFF) (FRANKFURT: MB31)

  • $0.1050

    CURRENT ($)

  • 0.00

    24-hour Change ($)

  • 0.00%

    24-hour Change (%)

Category Leading Brands For Everyone

  • Creating premium handcrafted cannabis products for all consumer needs

  • Adult Recreational

    Small batch handcrafted cannabis grown organically by Canada’s leading cultivation team consistently delivering high levels of THC and CBD

  • Therapeutic

    Pills and topicals designed to mitigate chronic pain and improve user lifestyle so you can focus on what you care about

  • Medical

    Direct to patient sales of high quality flower and CBD pills utilizing advanced encapsulation technology that delivers precise micro-dosing

An established and growing
global presence

With the ability to distribute nationally and internationally, Experion is positioned to consider every marketing opportunity available

Experion advantages

State-of-the-art facilities, scientific research, and key partnerships give Experion the clear upper hand

  • Advanced facility

    Traditional growing in a GMP capable state of the art cultivation and processing facility supported by Canada's premier cultivation experts

  • Research

    Developing a bank of over 60 genetic strains and administering Canada's first Stage 3 clinical trial for pain management with cannabis

  • Partnerships

    Driving shareholder value through productive partnerships with only the best cannabis producers, discerning retailers and innovative manufacturers

  • Global export

    Expertise, skill set and network to take advantage of global export opportunities

Press releases

  • Experion Continues to Lead the Handcrafted Cannabis Industry

    December 4th, 2019

  • Experion’s Head Grower of Award Winning Citizen Stash Brand Nominated for the 2019 Cannabis Awards as Top Master Grower

    October 28th, 2019

  • Experion Holdings Ltd Successfully Obtains DTC Eligibility for its Common Shares

    October 17th, 2019

  • Experion Provides Update on Commercial and Operations Activities

    September 25th, 2019

  • Experion Partners with Leading Hemp Supplier to Secure Access to Hemp-based CBD

    September 17th, 2019

  • Experion Engages Mackie Research Capital for Market Making Services

    September 16th, 2019

Public filings

The numbers

  • $5.2B

    Projected spend Adult-use cannabis in Canada by 2024 (USD)

  • $1.88B

    Potential size of the Medical marijuana market in Canada by 2025 (USD)

  • $2.03B

    Expected Canadian market size for alternative cannabis products annually starting 2020 (USD)

  • $66.3B

    Global cannabis spend by the end of 2025 (USD)

The key point

As the world continues to shift towards the legalization of cannabis, Experion has a unique advantage to distribute high quality flower and therapeutic products on a global platform

  • Expansion

    Optimize cultivation and processing capacity internally and with grow partners

  • Category Leading Brands

    Expand distribution and deepen brand awareness

  • Product Development

    Develop continuous rotation of premium high-quality cannabis strains for launch

LET’S CONFIRM YOU’RE AT LEGAL AGE TO ENTER OUR SITE.

You must be of legal age in accordance with the law of your province to access this website and/or to purchase cannabis. By entering this site you agree to our terms and conditions and privacy policy.